Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.008 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |